000			01987cam a22003377a 4500
999			_c6037 _d6037
001			13313664
003			KENaKMTC
005			20171106134953.0
008			030515s2003 sz a b i000 0 eng d
010			_a 2003362254
020			_a9241545992
035			_a(OCoLC)ocm52253251
040			_aPIT _cPIT _dVAM _dDLC
042			_alccopycat
050	0	0	_aRA997.W6 2003 _b.
082	0	0	_a362.16 _222
245	0	0	_aAdherence to long-term therapies : _bevidence for action / _c[edited by Eduardo Sabaté].
260			_aGeneva : _bWorld Health Organization, _cc2003.
300			_axv, 198 p. : _bcol. ill. ; _c26 cm.
504			_aIncludes bibliographical references.
505	0		_aSection I - Setting the scene Ch. I. Defining adherence -- Ch. II. The magnitude of the problem of poor adherence -- Ch. III. How does poor adherence affect policy makers and health managers? -- Section II - Improving adherence rates: guidance for countries Ch. IV. Lessons learned -- Ch. V. Towards the solution -- Ch. VI. How can improved adherence be translated into health and economics benefits? -- Section III - Disease-specific reviews Ch. VII. Asthma -- Ch. VIII. Cancer (palliative care) -- Ch. IX. Depression -- Ch. X. Diabetes -- Ch. XI. Epilepsy -- Ch. XII. HIV/AIDS -- Ch. XIII. Hypertension -- Ch. XIV. Tobacco smoking cessation -- Ch. XV. Tuberculosis -- Annexes Annex I. Behavioural mechanisms explaining adherence -- Annex II. Statements by stakeholders -- Annex III. Table of reported factors by condition and dimension -- Annex IV. Table of reported interventions by condition and dimension -- Annex V. Global adherence interdisciplinary network (GAIN).
650		0	_aChronic diseases _xTreatment.
650		0	_aPatient compliance.
650		0	_aMedical policy.
650	1	2	_aChronic Disease _xtherapy.
650	2	2	_aHealth Policy.
650	2	2	_aPatient Compliance.
700	1		_aSabaté, Eduardo.
710	2		_aWorld Health Organization.
906			_a7 _bcbc _ccopycat _d3 _encip _f20 _gy-gencatlg
942			_2lcc _cBK _xRJ